Diabetes Board decisions

The Board grants service connection for diabetes mellitus, type II, as secondary to the service-connected posttraumatic stress disorder (PTSD), low back disability with associated bilateral lower extremity radiculopathy, right ankle, and bilateral knee disabilities.

The Board remands the claims for service connection for diabetes, hypertension, and erectile dysfunction to allow for additional development, including verification of in-service toxic exposures and obtaining a medical opinion under the PACT Act.

The Board denied the Veteran's claim for a TDIU rating prior to August 27, 2024, as it was determined that he was not precluded from securing or following a substantially gainful occupation due to his service-connected disabilities.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board denied service connection for obesity and deviated septum, but remanded the claims of entitlement to service connection for bilateral pes planus and deviated septum for further development. The claim for diabetes was dismissed.

The Board granted service connection for type II diabetes mellitus, coronary artery disease with angina, myocardial infarction, and peripheral neuropathy of the bilateral lower and upper extremities due to exposure to herbicide agents during service. The claims for deep vein thrombosis and cellulitis were remanded.

The Board granted service connection for hypertension as it is a chronic disease that began during active service.

The Board granted service connection for diabetes mellitus type II and GERD, both as secondary to the Veteran's service-connected bilateral pes planus with plantar fasciitis and calluses of the feet.

The veteran withdrew the appeals for service connection for diabetes mellitus type II, hypertension, and Gastroesophageal reflux disease (GERD).

The Board remands the claims for service connection for prostate cancer, diabetes mellitus Type II, and erectile dysfunction due to pre-decisional duty to assist errors.

The Board denied service connection for chronic urinary tract infections, diabetes mellitus, benign prostatic hypertrophy, hyperparathyroidism and hypercalcemia, hypertension, and special monthly compensation based on aid and attendance/housebound status.

The Board denied the appellant's claim for direct payment of attorney fees from past due benefits awarded in an August 2023 rating decision granting service connection for Parkinson's disease and related symptoms.

The Board granted service connection for diabetes mellitus, type II on a facts-found basis effective May 8, 2019, but denied an increased rating in excess of 20 percent.

The Board granted service connection for diabetes mellitus and right foot Charcot joint neuropathy with mid-foot marrow edema as secondary to the service-connected diabetes mellitus.

The Board denied an initial rating in excess of 20 percent for Type II diabetes mellitus and remanded the issues of service connection for erectile dysfunction, a recurrent urinary disability to include urinary frequency, a recurrent liver disability to include non alcoholic fatty liver disease, and a recurrent gastrointestinal disability to include diverticulitis.

The Board denied service connection for posttraumatic stress disorder (PTSD) and remanded the claims for anxiety disorder with panic attacks, diabetes mellitus, gastritis with ulcerative colitis, and sinusitis.

The Board granted service connection for hypertension, diabetes mellitus type II, and coronary atherosclerosis due to in-service exposure to Agent Orange. Hypomagnesemia was denied as it is not considered a disability for VA compensation purposes.

The Board is remanding the issues of service connection for bladder cancer, prostate cancer, and diabetes mellitus for readjudication.

The appeal for a total disability rating based on individual unemployability (TDIU) is dismissed, and the claims for service connection for diabetes mellitus and peripheral neuropathy of the bilateral lower extremities are remanded.

The Board granted service connection for type II diabetes mellitus, coronary artery disease with angina, myocardial infarction, and peripheral neuropathy of the bilateral lower and upper extremities due to exposure to herbicide agents during service. The claims for deep vein thrombosis and cellulitis were remanded.